Allotment of ESOP / ESPS
Allotment of 27,028 Equity Shares under Jyothy Laboratories Employees Stock Option Scheme (ESOS-2014) as per the resolution passed by the ESOP Allotment Committee on November 21, 201721-11-2017
21-11-2017
Financial Results For The Quarter Ended September 30, 2017
Unaudited Standalone & Consolidated Financial Results along with the Limited Review Report & Press Release for the quarter ended September 30, 201708-11-2017
Henkel calls off talks to buy 26% stake in Jyothy Labs
Henkel chose not to buy a stake in Jyothy Labs because the companies were not happy with the direction the talks were taking, MD Ulhas Kamath said08-11-2017
Allotment of ESOP / ESPS
ESOP Allotment Committee of Board of Directors of the Company at its meeting held today has issued and allotted 29,280 (Twenty Nine Thousand Two Hundred and Eighty) Equity Shares of face value of Re.1/- each to the eligible employees of the Company under 'Jyothy Laboratories Employees Stock Options Scheme (ESOS 2014)'07-11-2017
Investor Presentation
Copy of Presentation on the Company's performance for the quarter and half year ended September 30, 201707-11-2017
Unaudited Standalone And Consolidated Financial Results For The Quarter And Half-Year Ended September 30, 2017
With reference to the captioned subject, we wish to inform you that the Board of Directors of the Company at its meeting held today at 11.35 a.m. and concluded at 1.15 p.m., approved the Unaudited Standalone and Consolidated Financial Results with Limited Review by the Statutory Auditors of the Company for the quarter and half year ended September 30, 2017. A copy of the said Unaudited Financial Results accompanied with the Limited Review Report...07-11-2017
Updates
Transfer of Equity Shares of the Company to Investor Education and Protection Fund (IEPF) Account04-11-2017
Earnings Call Transcript
Intimation of Schedule of Earnings Call for Analyst(s) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 at 4.00 p.m. on Tuesday, November 7, 2017, subsequent to declaration of its financial results for the quarter and half year ended September 30, 201701-11-2017
Board Meeting On October 31, 2017
Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a Meeting of the Board of Directors of Jyothy Laboratories Limited (hereinafter referred to as 'the Company') is scheduled to be held on Tuesday, November 7, 2017, inter-alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter...31-10-2017
Half Yearly Certificate Under Regulation 40(9) Of The Listing Regulations, 2015
Half yearly certificate under Regulation 40(9) of the Listing Regulations, 2015 for the half year ended September 30, 2017 issued by Mr. Anish Gupta- Practicing Company Secretary12-10-2017